Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Rallybio Corporation Common Stock (RLYB)

Pharmaceutical Preparations

https://www.rallybio.com

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

234 CHURCH STREET, SUITE 1020
NEW HAVEN, CT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/29/2021

Market Cap

45,594,230

Shares Outstanding

37,790,000

Weighted SO

37,793,705

Total Employees

N/A

Upcoming Earnings

08/13/2024

Beta

-1.6850

Last Div

0.0000

Range

1.09-5.96

Chg

-0.0100

Avg Vol

209593

Mkt Cap

45594230

Exch

NASDAQ

Country

US

Phone

203 859 3820

DCF Diff

0.5241

DCF

0.5959

Div Yield

0.0000

P/S

86.5166

EV Multiple

-0.3784

P/FV

0.6066

Div Yield %

0.0000

P/E

-0.6570

PEG

-0.0549

Payout

0.0000

Current Ratio

7.5188

Quick Ratio

7.5188

Cash Ratio

1.3709

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

3130.7746

CCC

-3130.7746

Gross Margin

0.7306

Op Margin

-146.6736

Pretax Margin

-136.8046

Net Margin

-140.1917

Eff Tax Rate

-0.0242

ROA

-0.7993

ROE

-0.7408

ROCE

-0.9630

NI/EBT

1.0248

EBT/EBIT

0.9327

EBIT/Rev

-146.6736

Debt Ratio

0.0031

D/E

0.0035

LT Debt/Cap

0.0007

Total Debt/Cap

0.0035

Int Coverage

-46.6206

CF/Debt

-190.1092

Equity Multi

1.1551

Rec Turnover

0.0000

Pay Turnover

0.1166

Inv Turnover

0.0000

FA Turnover

1.2342

Asset Turnover

0.0057

OCF/Share

-1.2235

FCF/Share

-1.2238

Cash/Share

2.0081

OCF/Sales

-102.4497

FCF/OCF

1.0003

CF Coverage

-190.1092

ST Coverage

-238.8982

CapEx Coverage

-3582.6808

Div&CapEx Cov

-3582.6808

P/BV

0.6066

P/B

0.6066

P/S

86.5166

P/E

-0.6570

P/FCF

-0.8442

P/OCF

-0.8991

P/CF

-0.8991

PEG

-0.0549

P/S

86.5166

EV Multiple

-0.3784

P/FV

0.6066

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation